Business description: PCAS

PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows:

- synthesized pharmaceutical products (63.5%);

- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).

At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.

France accounts for 76% of net sales.

Number of employees: 1,178

Sales by Activity: PCAS

Fiscal Period: December 2019 (EUR) 2020 (EUR) 2021 (EUR) 2022 (EUR)

Pharmaceutical Synthesis

128M 135M 120M 144M

Fine Speciality Chemicals

73.25M 58.92M 67.41M 82.72M

Geographical breakdown of sales: PCAS

Fiscal Period: December 2019 (EUR) 2020 (EUR) 2021 (EUR) 2022 (EUR)

France

163M 155M 143M 172M

Other Areas

38.01M 38.92M 44.36M 54.3M

Executive Committee: PCAS

Manager TitleAgeSince
Chief Executive Officer 43 2025-05-02
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 1999-02-28

Composition of the Board of Directors: PCAS

Director TitleAgeSince
Director/Board Member 74 2014-02-28
Director/Board Member - -

Company details: PCAS

PCAS SA

21, Chemin de la Sauvegarde

69134, Écully

+33 1 69 09 77 85

address PCAS(PCA)

Other Pharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-0.47%+72.43%+119.36% 1,052B
-0.66%+0.43%+49.01%+50.11% 627B
-0.54%+1.39%+21.88%+63.83% 441B
-1.99%-3.32%+41.98%+34.08% 349B
-1.05%-2.81%+24.22%+34.67% 287B
-2.12%-3.67%-1.09%+3.11% 241B
-0.63%+1.04%+43.03%+59.10% 224B
-1.19%-3.41%-9.18%-52.41% 202B
+0.16%+3.87%+16.25%+73.27% 172B
Average -0.66%+0.43%+28.73%+42.79% 399.46B
Weighted average by Cap. -0.09%+0.32%+41.31%+62.03%